Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Project Suzetrigine: The Efficacy and Safety of Suzetrigine (Journavx™) Following Total Ankle Arthroplasty: an Exploratory Prospective Cohort Study

NCT07795827 is registered in ClinicalTrials.gov with Soheil Ashkani Esfahani as lead sponsor.

NCT NCT07795827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07795827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Project Suzetrigine: The Efficacy and Safety of Suzetrigine (Journavx™) Following Total Ankle Arthroplasty: an Exploratory Prospective Cohort Study
Lead sponsor
Soheil Ashkani Esfahani
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
April 1, 2028
Enrollment
28 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, ankle osteoarthritis, postoperative pain